User contributions
From 2012.igem.org
(Latest | Earliest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 20:52, 26 September 2012 (diff | hist) m Team:Wageningen UR/ObtainingthePoleroVLP (→Polerovirus Natural BioBrick)
- 20:36, 26 September 2012 (diff | hist) m Template:WUR
- 20:25, 26 September 2012 (diff | hist) m Team:Wageningen UR/OutsideModification (→Polerovirus)
- 19:24, 26 September 2012 (diff | hist) m Team:Wageningen UR/Virus-related issues
- 19:21, 26 September 2012 (diff | hist) m Team:Wageningen UR/Virus-related issues (→2. Virus-related safety)
- 19:19, 26 September 2012 (diff | hist) m Team:Wageningen UR/Safety (→Key Questions (Summary))
- 19:13, 26 September 2012 (diff | hist) m Team:Wageningen UR/Parts (→Parts)
- 19:11, 26 September 2012 (diff | hist) m Team:Wageningen UR/Parts (→Faulty parts)
- 19:10, 26 September 2012 (diff | hist) m Team:Wageningen UR/Parts (→Faulty parts)
- 19:07, 26 September 2012 (diff | hist) m Team:Wageningen UR/Parts (→Parts)
- 18:54, 26 September 2012 (diff | hist) m Team:Wageningen UR/OutsideModification (→Polerovirus)
- 16:41, 26 September 2012 (diff | hist) m Team:Wageningen UR/FinalOverview (→Final Overview)
- 16:41, 26 September 2012 (diff | hist) m Team:Wageningen UR/FinalOverview (→Final Overview)
- 16:40, 26 September 2012 (diff | hist) m Team:Wageningen UR/FinalOverview (→Final Overview)
- 16:40, 26 September 2012 (diff | hist) m Team:Wageningen UR/FinalOverview (→Final Overview)
- 16:39, 26 September 2012 (diff | hist) m Team:Wageningen UR/FinalOverview (→Final Overview)
- 16:38, 26 September 2012 (diff | hist) m Team:Wageningen UR/FinalOverview (→Final Overview)
- 16:31, 26 September 2012 (diff | hist) m Team:Wageningen UR/FinalOverview (→Final Overview)
- 16:27, 26 September 2012 (diff | hist) m Team:Wageningen UR/Human Practices (→Human practices)
- 16:26, 26 September 2012 (diff | hist) m Team:Wageningen UR/Human Practices (→Human practices)
- 16:26, 26 September 2012 (diff | hist) m Team:Wageningen UR/Human Practices
- 16:25, 26 September 2012 (diff | hist) m Team:Wageningen UR/Human Practices
- 16:22, 26 September 2012 (diff | hist) m Team:Wageningen UR/FinalOverview (→Final Overview)
- 16:17, 26 September 2012 (diff | hist) m Team:Wageningen UR/FinalOverview (→Final Overview)
- 16:12, 26 September 2012 (diff | hist) m Team:Wageningen UR/FinalOverview
- 16:02, 26 September 2012 (diff | hist) m Team:Wageningen UR/FinalOverview (→Final Overview)
- 15:51, 26 September 2012 (diff | hist) m Team:Wageningen UR/OutsideModification (→Polerovirus)
- 15:44, 26 September 2012 (diff | hist) m Team:Wageningen UR/Protocol/FormationBufferPolero (→Formation Buffer Polero)
- 15:43, 26 September 2012 (diff | hist) m Team:Wageningen UR/Protocol/FormationBufferPolero
- 15:43, 26 September 2012 (diff | hist) N Team:Wageningen UR/Protocol/FormationBufferPolero (Created page with "{{Template:WUR}} == Formation Buffer HepBcAg == Ingredients: * 0.117% monosodium phosphate, monohydrate 1.167 g/L * 0.309% disodium phosphate, heptahydrate 3.093 g/L ...")
- 15:33, 26 September 2012 (diff | hist) m Team:Wageningen UR/Protocol
- 15:31, 26 September 2012 (diff | hist) N Team:Wageningen UR/Protocol/RoundupPolero (Created page with "{{Template:WUR}} == Materials: == <ul> <li>Pipettes + Pipette tips</li> <li>Eppendorf tubes</li> <li>Greiner tubes</li> <li>Centrikon or a similar ultracentrifuge + all additio...") (top)
- 15:29, 26 September 2012 (diff | hist) m Team:Wageningen UR/Protocol/StartupCCMV
- 15:28, 26 September 2012 (diff | hist) N Team:Wageningen UR/Protocol/StartupPolero (Created page with "{{Template:Ecoil}} = Growing Culture = == Reagents & Materials == For a 100 mL batch: Reagents: <ul> <li>110 mL of LB</li> <li>kanamycin</li> <li>0.5 mL of IPTG stock solutio...")
- 15:26, 26 September 2012 (diff | hist) m Team:Wageningen UR/Protocol/DialysisPolero
- 15:25, 26 September 2012 (diff | hist) m Team:Wageningen UR/Protocol
- 15:22, 26 September 2012 (diff | hist) N Team:Wageningen UR/Protocol/DialysisPolero (Created page with "{{Template:WUR}} = Dialysis of the VLPs = This protocol is based on the CCMV VLP formation protocol. We made adjustments because HepBcAg has a different pH at which the particl...")
- 15:10, 26 September 2012 (diff | hist) m Team:Wageningen UR/Possible Improvements
- 15:08, 26 September 2012 (diff | hist) m Team:Wageningen UR/Virus-related issues (→References)
- 15:08, 26 September 2012 (diff | hist) m Team:Wageningen UR/Regulations
- 15:08, 26 September 2012 (diff | hist) m Team:Wageningen UR/Virus-related issues
- 15:06, 26 September 2012 (diff | hist) m Team:Wageningen UR/General safety
- 15:05, 26 September 2012 (diff | hist) m Team:Wageningen UR/Safety
- 15:02, 26 September 2012 (diff | hist) m Team:Wageningen UR/Possible Improvements
- 15:00, 26 September 2012 (diff | hist) Team:Wageningen UR/Regulations
- 14:58, 26 September 2012 (diff | hist) m Team:Wageningen UR/Virus-related issues
- 14:53, 26 September 2012 (diff | hist) m Team:Wageningen UR/General safety
- 14:22, 26 September 2012 (diff | hist) m Team:Wageningen UR/Human Practices (→Human practices)
- 14:19, 26 September 2012 (diff | hist) Team:Wageningen UR/Human Practices
- 20:00, 25 September 2012 (diff | hist) Team:Wageningen UR/CASconference
(Latest | Earliest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)